Puma Biotechnology (PBYI) Inventory (2017 - 2026)

Puma Biotechnology's Inventory history runs 10 years deep, the most recent figure standing at $8.7 million for Q1 2026.

• Quarterly Inventory fell 0.66% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (down 0.66% YoY) and the FY2025 annual result came in at $5.5 million, down 36.78% from the prior year.
• Inventory was $8.7 million for Q1 2026 at Puma Biotechnology, up from $5.5 million in the prior quarter.
• Across five years, Inventory topped out at $9.5 million in Q3 2025 and bottomed at $2.7 million in Q3 2024.
• A 5-year average of $6.9 million and a median of $7.1 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory plunged 52.93% — and 2025, when it surged 254.51%.
• Puma Biotechnology's Inventory stood at $4.5 million in 2022, then surged by 56.43% to $7.1 million in 2023, then grew by 23.22% to $8.7 million in 2024, then plunged by 36.78% to $5.5 million in 2025, then surged by 57.62% to $8.7 million in 2026.
• Business Quant data shows PBYI's Inventory at $8.7 million in Q1 2026, $5.5 million in Q4 2025, and $9.5 million in Q3 2025.